3.26.1 html 173 291 1 false 59 0 false 7 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.x4pharma.com/role/CoverPage Cover Page Cover 1 false false R2.htm 9952151 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 9952152 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME Sheet http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSINCOME CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME Statements 4 false false R5.htm 9952154 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 9952155 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 9952156 - Disclosure - Description of Business and Summary of Significant Accounting Policies Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPolicies Description of Business and Summary of Significant Accounting Policies Notes 7 false false R8.htm 9952157 - Disclosure - Strategic Restructuring Liability Sheet http://www.x4pharma.com/role/StrategicRestructuringLiability Strategic Restructuring Liability Notes 8 false false R9.htm 9952158 - Disclosure - License Agreements Sheet http://www.x4pharma.com/role/LicenseAgreements License Agreements Notes 9 false false R10.htm 9952159 - Disclosure - Revenue Sheet http://www.x4pharma.com/role/Revenue Revenue Notes 10 false false R11.htm 9952160 - Disclosure - Inventory Sheet http://www.x4pharma.com/role/Inventory Inventory Notes 11 false false R12.htm 9952161 - Disclosure - Property and Equipment Sheet http://www.x4pharma.com/role/PropertyandEquipment Property and Equipment Notes 12 false false R13.htm 9952162 - Disclosure - Intangible Asset, Net Sheet http://www.x4pharma.com/role/IntangibleAssetNet Intangible Asset, Net Notes 13 false false R14.htm 9952163 - Disclosure - Accrued Expenses Sheet http://www.x4pharma.com/role/AccruedExpenses Accrued Expenses Notes 14 false false R15.htm 9952164 - Disclosure - Long-Term Debt Sheet http://www.x4pharma.com/role/LongTermDebt Long-Term Debt Notes 15 false false R16.htm 9952165 - Disclosure - Leases Sheet http://www.x4pharma.com/role/Leases Leases Notes 16 false false R17.htm 9952166 - Disclosure - Commitment and Contingencies Sheet http://www.x4pharma.com/role/CommitmentandContingencies Commitment and Contingencies Notes 17 false false R18.htm 9952167 - Disclosure - Equity Transactions Sheet http://www.x4pharma.com/role/EquityTransactions Equity Transactions Notes 18 false false R19.htm 9952168 - Disclosure - Stock-Based Compensation Sheet http://www.x4pharma.com/role/StockBasedCompensation Stock-Based Compensation Notes 19 false false R20.htm 9952169 - Disclosure - Income Taxes Sheet http://www.x4pharma.com/role/IncomeTaxes Income Taxes Notes 20 false false R21.htm 9952170 - Disclosure - Segment Information Sheet http://www.x4pharma.com/role/SegmentInformation Segment Information Notes 21 false false R22.htm 9952171 - Disclosure - Subsequent Events Sheet http://www.x4pharma.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 23 false false R24.htm 9955511 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies Description of Business and Summary of Significant Accounting Policies (Policies) Policies http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPolicies 24 false false R25.htm 9955512 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Tables) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables Description of Business and Summary of Significant Accounting Policies (Tables) Tables http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPolicies 25 false false R26.htm 9955513 - Disclosure - Strategic Restructuring Liability (Tables) Sheet http://www.x4pharma.com/role/StrategicRestructuringLiabilityTables Strategic Restructuring Liability (Tables) Tables http://www.x4pharma.com/role/StrategicRestructuringLiability 26 false false R27.htm 9955514 - Disclosure - Revenue (Tables) Sheet http://www.x4pharma.com/role/RevenueTables Revenue (Tables) Tables http://www.x4pharma.com/role/Revenue 27 false false R28.htm 9955515 - Disclosure - Inventory (Tables) Sheet http://www.x4pharma.com/role/InventoryTables Inventory (Tables) Tables http://www.x4pharma.com/role/Inventory 28 false false R29.htm 9955516 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.x4pharma.com/role/PropertyandEquipmentNetTables Property and Equipment, Net (Tables) Tables http://www.x4pharma.com/role/PropertyandEquipment 29 false false R30.htm 9955517 - Disclosure - Intangible Asset, Net (Tables) Sheet http://www.x4pharma.com/role/IntangibleAssetNetTables Intangible Asset, Net (Tables) Tables http://www.x4pharma.com/role/IntangibleAssetNet 30 false false R31.htm 9955518 - Disclosure - Accrued Expenses (Tables) Sheet http://www.x4pharma.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://www.x4pharma.com/role/AccruedExpenses 31 false false R32.htm 9955519 - Disclosure - Long-Term Debt (Tables) Sheet http://www.x4pharma.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://www.x4pharma.com/role/LongTermDebt 32 false false R33.htm 9955520 - Disclosure - Leases (Tables) Sheet http://www.x4pharma.com/role/LeasesTables Leases (Tables) Tables http://www.x4pharma.com/role/Leases 33 false false R34.htm 9955521 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.x4pharma.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.x4pharma.com/role/StockBasedCompensation 34 false false R35.htm 9955522 - Disclosure - Segment Information (Tables) Sheet http://www.x4pharma.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.x4pharma.com/role/SegmentInformation 35 false false R36.htm 9955523 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails Description of Business and Summary of Significant Accounting Policies - Additional Information (Details) Details 36 false false R37.htm 9955524 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Schedule of Compensating Balance Arrangements (Detail) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesScheduleofCompensatingBalanceArrangementsDetail Description of Business and Summary of Significant Accounting Policies - Schedule of Compensating Balance Arrangements (Detail) Details 37 false false R38.htm 9955525 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash (Detail) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesScheduleofReconciliationofCashCashEquivalentsandRestrictedCashDetail Description of Business and Summary of Significant Accounting Policies - Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash (Detail) Details 38 false false R39.htm 9955526 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Assets Measured on a Recurring Basis (Details) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesAssetsMeasuredonaRecurringBasisDetails Description of Business and Summary of Significant Accounting Policies - Assets Measured on a Recurring Basis (Details) Details 39 false false R40.htm 9955527 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Debt Securities Available for Sale (Details) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDebtSecuritiesAvailableforSaleDetails Description of Business and Summary of Significant Accounting Policies - Debt Securities Available for Sale (Details) Details 40 false false R41.htm 9955528 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Liabilities Measured at Fair Value (Details) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesLiabilitiesMeasuredatFairValueDetails Description of Business and Summary of Significant Accounting Policies - Liabilities Measured at Fair Value (Details) Details 41 false false R42.htm 9955529 - Disclosure - Description of Business and Summary of Significant Accounting Policies Aggregate Fair Value of Financial Instruments (Details) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesAggregateFairValueofFinancialInstrumentsDetails Description of Business and Summary of Significant Accounting Policies Aggregate Fair Value of Financial Instruments (Details) Details 42 false false R43.htm 9955530 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Fair Value Assumptions (Details) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesFairValueAssumptionsDetails Description of Business and Summary of Significant Accounting Policies - Fair Value Assumptions (Details) Details 43 false false R44.htm 9955531 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Summary of Stock-Based Compensation Expense Classification (Details) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesSummaryofStockBasedCompensationExpenseClassificationDetails Description of Business and Summary of Significant Accounting Policies - Summary of Stock-Based Compensation Expense Classification (Details) Details 44 false false R45.htm 9955532 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Earnings Per Share (Details) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesEarningsPerShareDetails Description of Business and Summary of Significant Accounting Policies - Earnings Per Share (Details) Details 45 false false R46.htm 9955533 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Share (Details) Sheet http://www.x4pharma.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedNetLossperShareDetails Description of Business and Summary of Significant Accounting Policies - Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Share (Details) Details 46 false false R47.htm 9955534 - Disclosure - Strategic Restructuring Liability - Narrative (Details) Sheet http://www.x4pharma.com/role/StrategicRestructuringLiabilityNarrativeDetails Strategic Restructuring Liability - Narrative (Details) Details 47 false false R48.htm 9955535 - Disclosure - Strategic Restructuring Liability - Reserve Rollforward (Details) Sheet http://www.x4pharma.com/role/StrategicRestructuringLiabilityReserveRollforwardDetails Strategic Restructuring Liability - Reserve Rollforward (Details) Details 48 false false R49.htm 9955536 - Disclosure - Revenue - Narrative (Details) Sheet http://www.x4pharma.com/role/RevenueNarrativeDetails Revenue - Narrative (Details) Details 49 false false R50.htm 9955537 - Disclosure - Revenue - Product Revenue, Net (Details) Sheet http://www.x4pharma.com/role/RevenueProductRevenueNetDetails Revenue - Product Revenue, Net (Details) Details 50 false false R51.htm 9955538 - Disclosure - Revenue - Rollforward of Accounts Receivable (Details) Sheet http://www.x4pharma.com/role/RevenueRollforwardofAccountsReceivableDetails Revenue - Rollforward of Accounts Receivable (Details) Details 51 false false R52.htm 9955539 - Disclosure - Revenue - Allocation of Performance Obligation (Details) Sheet http://www.x4pharma.com/role/RevenueAllocationofPerformanceObligationDetails Revenue - Allocation of Performance Obligation (Details) Details 52 false false R53.htm 9955540 - Disclosure - Revenue - Rollforward of Deferred Revenue (Details) Sheet http://www.x4pharma.com/role/RevenueRollforwardofDeferredRevenueDetails Revenue - Rollforward of Deferred Revenue (Details) Details 53 false false R54.htm 9955541 - Disclosure - Inventory (Details) Sheet http://www.x4pharma.com/role/InventoryDetails Inventory (Details) Details http://www.x4pharma.com/role/InventoryTables 54 false false R55.htm 9955542 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail) Sheet http://www.x4pharma.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentNetDetail Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail) Details 55 false false R56.htm 9955543 - Disclosure - Property and Equipment, Net - Additional Information (Detail) Sheet http://www.x4pharma.com/role/PropertyandEquipmentNetAdditionalInformationDetail Property and Equipment, Net - Additional Information (Detail) Details 56 false false R57.htm 9955544 - Disclosure - Intangible Asset, Net (Details) Sheet http://www.x4pharma.com/role/IntangibleAssetNetDetails Intangible Asset, Net (Details) Details http://www.x4pharma.com/role/IntangibleAssetNetTables 57 false false R58.htm 9955545 - Disclosure - Intangible Asset, Net - Narrative (Details) Sheet http://www.x4pharma.com/role/IntangibleAssetNetNarrativeDetails Intangible Asset, Net - Narrative (Details) Details 58 false false R59.htm 9955546 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Detail) Sheet http://www.x4pharma.com/role/AccruedExpensesScheduleofAccruedExpensesDetail Accrued Expenses - Schedule of Accrued Expenses (Detail) Details 59 false false R60.htm 9955547 - Disclosure - Long-Term Debt - Summary of Long Term Debt (Detail) Sheet http://www.x4pharma.com/role/LongTermDebtSummaryofLongTermDebtDetail Long-Term Debt - Summary of Long Term Debt (Detail) Details 60 false false R61.htm 9955548 - Disclosure - Long Term Debt - Hercules Loan Agreement - Additional Information (Detail) Sheet http://www.x4pharma.com/role/LongTermDebtHerculesLoanAgreementAdditionalInformationDetail Long Term Debt - Hercules Loan Agreement - Additional Information (Detail) Details 61 false false R62.htm 9955549 - Disclosure - Long-Term Debt - Summary of Interest Expense (Details) Sheet http://www.x4pharma.com/role/LongTermDebtSummaryofInterestExpenseDetails Long-Term Debt - Summary of Interest Expense (Details) Details 62 false false R63.htm 9955550 - Disclosure - Leases - Additional Information (Detail) Sheet http://www.x4pharma.com/role/LeasesAdditionalInformationDetail Leases - Additional Information (Detail) Details 63 false false R64.htm 9955551 - Disclosure - Leases - Schedule of Components of Lease Expense (Detail) Sheet http://www.x4pharma.com/role/LeasesScheduleofComponentsofLeaseExpenseDetail Leases - Schedule of Components of Lease Expense (Detail) Details 64 false false R65.htm 9955552 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Detail) Sheet http://www.x4pharma.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetail Leases - Schedule of Maturities of Lease Liabilities (Detail) Details 65 false false R66.htm 9955553 - Disclosure - Commitment and Contingencies - Additional Information (Detail) Sheet http://www.x4pharma.com/role/CommitmentandContingenciesAdditionalInformationDetail Commitment and Contingencies - Additional Information (Detail) Details 66 false false R67.htm 9955554 - Disclosure - Equity Transactions - Additional Information (Detail) Sheet http://www.x4pharma.com/role/EquityTransactionsAdditionalInformationDetail Equity Transactions - Additional Information (Detail) Details 67 false false R68.htm 9955555 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.x4pharma.com/role/StockBasedCompensationAdditionalInformationDetail Stock-Based Compensation - Additional Information (Detail) Details 68 false false R69.htm 9955556 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option-Pricing Model to Determine Grant-date Fair Value of Stock Options Granted (Detail) Sheet http://www.x4pharma.com/role/StockBasedCompensationScheduleofAssumptionsUsedinBlackScholesOptionPricingModeltoDetermineGrantdateFairValueofStockOptionsGrantedDetail Stock-Based Compensation - Schedule of Assumptions Used in Black-Scholes Option-Pricing Model to Determine Grant-date Fair Value of Stock Options Granted (Detail) Details 69 false false R70.htm 9955557 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) Sheet http://www.x4pharma.com/role/StockBasedCompensationSummaryofStockOptionActivityDetail Stock-Based Compensation - Summary of Stock Option Activity (Detail) Details 70 false false R71.htm 9955558 - Disclosure - Stock-Based Compensation - Restricted Stock Units (Details) Sheet http://www.x4pharma.com/role/StockBasedCompensationRestrictedStockUnitsDetails Stock-Based Compensation - Restricted Stock Units (Details) Details 71 false false R72.htm 9955559 - Disclosure - Stock-Based Compensation Summary of Stock-Based Compensation Expense Classification (Details) Sheet http://www.x4pharma.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseClassificationDetails Stock-Based Compensation Summary of Stock-Based Compensation Expense Classification (Details) Details 72 false false R73.htm 9955560 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.x4pharma.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 73 false false R74.htm 9955561 - Disclosure - Segment Information (Details) Sheet http://www.x4pharma.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.x4pharma.com/role/SegmentInformationTables 74 false false All Reports Book All Reports xfor-20260331.htm xfor-20260331.xsd xfor-20260331_cal.xml xfor-20260331_def.xml xfor-20260331_lab.xml xfor-20260331_pre.xml http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true